Difference between revisions of "Government Accountability Office"
Jump to navigation
Jump to search
Aziraphale (talk | contribs) (categorize) |
|||
| Line 2: | Line 2: | ||
For example, a recent report of the GAO concluded that between 1993 and 2004 annual research and development spending by the pharmaceutical industry increased 147 percent, to $60 billion. But the report observed during the same period the number of new drug applications to the FDA grew by only 38 percent, and that new applications have generally declined since 1999. | For example, a recent report of the GAO concluded that between 1993 and 2004 annual research and development spending by the pharmaceutical industry increased 147 percent, to $60 billion. But the report observed during the same period the number of new drug applications to the FDA grew by only 38 percent, and that new applications have generally declined since 1999. | ||
| + | |||
| + | [[category:United States Government]] | ||
Revision as of 19:55, July 23, 2007
The Government Accountability Office (GAO) is the investigative arm of Congress, which generates reports for congressmen and the public.
For example, a recent report of the GAO concluded that between 1993 and 2004 annual research and development spending by the pharmaceutical industry increased 147 percent, to $60 billion. But the report observed during the same period the number of new drug applications to the FDA grew by only 38 percent, and that new applications have generally declined since 1999.